Document is current
Any future updates will be listed below
-
Authors
Ballion, Bérengère
Bonnet, Marie-Laure
Brot, Sébastien
Gaillard, Afsaneh https://orcid.org/0000-0002-9375-6506
-
Funding
Funding for this research was provided by:
Fondation de France (66517)
Fondation pour la Recherche Médicale (Victor and Erminia Mescle price)
- License Information
-
More Information
Article History
Received: 17 August 2024
Accepted: 15 April 2025
First Online: 9 May 2025
Declarations
:
: Experimental referenced procedures are performed in accordance with European legislative, administrative, and statutory authorities for animal experimentation (EU/Directive/2010/63 of the European Parliament and Council) and according to the guidelines of the Declaration of Helsinki. They were approved by ethics regional committee (N°84 COMETHEA Poitou-Charentes) and referenced under file number APAFIS#2019060311226483v2 (Project title: Reconstruction of damaged circuits by human stem cell transplantation in Parkinson’s disease / Date of approval 09/03/2019). All efforts are made to reduce animal number and their suffering.
: The human fibroblasts are sourced from the CliniSciences Company and are derived from human samples anonymously collected from donor biopsy. CliniSciences has authorisation for the importation and distribution of elements derived from the human body (French Ministry in charge of research, AC-2018-3168 and IE-2018-982) to their transfer for scientific purposes (Article L. 1243-3 and L. 12434 of the French Public Health Code - transposition of European Directive 2004/23/EC of 31 March 2004- ). Furthermore, CliniSciences Company confirms that all elements derived from the human body are sourced from donors who signed an informed consent form.
: the authors declare no interest conflicts regarding the publication of this paper.
